ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,700Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 2094

$1.61M Total Retail Price of All Prescriptions

Rank: 21 out of 2094

618 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 618 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 618 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 14,109 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 654 497 1 2
LEVOTHYROXINE SODIUM 567 438 2 3
METOPROLOL TARTRATE 501 366 3 10
HYDROCODONE-ACETAMINOPHEN 490 285 S3 4 42
FUROSEMIDE 466 286 5 6
SIMVASTATIN 429 333 6 1
PANTOPRAZOLE SODIUM 418 266 7 37
SERTRALINE HCL 382 232 8 26
FAMOTIDINE 354 276 9 34
OMEPRAZOLE 344 233 10 4
ZOLPIDEM TARTRATE 330 206 11 14
ATORVASTATIN CALCIUM 321 238 12 5
DIOVAN 320 251 13 13
CARVEDILOL 304 190 14 19
LISINOPRIL 302 192 15 7
RISPERIDONE 295 258 16 56
GABAPENTIN 287 114 17 23
METOPROLOL SUCCINATE 284 193 18 9
OXYCODONE-ACETAMINOPHEN 277 120 S2 19 40
DONEPEZIL HCL 272 245 20 20
QUETIAPINE FUMARATE 260 193 21 71
LACTULOSE 215 124 22 65
OXYCODONE HCL 200 53 S2 23 63
WARFARIN SODIUM 195 117 24 11
TRAMADOL HCL 187 144 25 33
CITALOPRAM HBR 186 142 26 47
IBUPROFEN 184 84 27 73
METFORMIN HCL 182 87 28 8
CRESTOR 177 119 29 15
TAMSULOSIN HCL 172 138 30 29
CYMBALTA 171 122 31 61
SPIRIVA 168 108 32 60
KLOR-CON M20 156 65 33 106
NEXIUM 145 101 34 16
ESCITALOPRAM OXALATE 142 119 35 46
BENZTROPINE MESYLATE 141 108 R 36 157
FENTANYL 135 43 S2 37 68
LIDODERM 134 58 38 59
ISOSORBIDE MONONITRATE ER 133 83 39 57
CARBIDOPA-LEVODOPA 132 102 40 102
NOVOLOG FLEXPEN 129 51 41 142
NAMENDA 129 129 41 32
DIGOXIN 127 91 43 51
QUINAPRIL HCL 123 87 44 123
SEROQUEL 123 93 44 172
ADVAIR DISKUS 122 100 46 36
LANTUS 116 46 47 66
CLOPIDOGREL 112 62 48 22
POTASSIUM CHLORIDE 111 72 49 24
HYDROMORPHONE HCL 110 21 S2 50 225
FLUOXETINE HCL 108 61 51 139
GLIMEPIRIDE 107 79 52 31
ROPINIROLE HCL 106 76 53 235
CARBAMAZEPINE 105 63 54 206
MEGESTROL ACETATE 105 69 R 54 174
PLAVIX 102 77 56 38
TRAZODONE HCL 102 58 56 72
DIVALPROEX SODIUM 100 61 58 69
MIRTAZAPINE 99 87 59 43
LEVETIRACETAM 99 63 59 78
SYMBICORT 98 69 61 149
DICYCLOMINE HCL 98 32 61 276
AZITHROMYCIN 98 63 61 27
CLONIDINE HCL 96 78 64 62
LYRICA 96 56 64 85
CYCLOBENZAPRINE HCL 95 52 R 66 115
SINGULAIR 93 61 67 64
BISOPROLOL-HYDROCHLOROTHIAZIDE 93 85 67 148
CIPROFLOXACIN HCL 93 73 67 81
RANITIDINE HCL 89 48 70 80
ATENOLOL 88 81 71 21
OLANZAPINE 88 75 71 113
LEVEMIR FLEXPEN 82 31 73 188
LANTUS SOLOSTAR 79 32 74 76
VENTOLIN HFA 77 45 75 132
VENLAFAXINE HCL ER 75 63 76 183
ALENDRONATE SODIUM 75 68 76 30
XIFAXAN 74 18 78 354
OXYCONTIN 73 26 S2 79 98
HYDRALAZINE HCL 73 55 79 89
HALOPERIDOL 73 26 79 196
FINASTERIDE 72 53 82 97
BUMETANIDE 71 45 83 236
FLUTICASONE PROPIONATE 70 23 84 41
SPIRONOLACTONE 69 45 85 93
PROAIR HFA 69 41 85 45
RAMIPRIL 67 62 87 48
LIPITOR 66 53 88 39
OXYBUTYNIN CHLORIDE 66 45 88 224
ALLOPURINOL 65 33 90 50
BETAMETHASONE DIPROPIONATE 64 52 91 202
ACEBUTOLOL HCL 63 31 92 473
VESICARE 62 55 93 152
ENALAPRIL MALEATE 61 48 94 25
TOPIRAMATE 61 37 94 199
NOVOLOG 59 16 96 116
PREDNISONE 59 36 96 54
PHENYTOIN SODIUM EXTENDED 59 23 96 158
DETROL LA 57 52 99 233
BACLOFEN 57 30 99 166
GLIPIZIDE 56 41 101 82
LEVEMIR 56 20 101 241
CELEBREX 55 24 103 74
PROMETHAZINE HCL 54 23 R 104 184
CEPHALEXIN 54 33 104 201
BISOPROLOL FUMARATE 53 51 106 237
HYDROXYZINE HCL 52 33 R 107 232
NORTRIPTYLINE HCL 52 27 107 379
PRAVASTATIN SODIUM 52 26 107 18
LOSARTAN POTASSIUM 51 46 110 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 34 111 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.